Cardiac Amyloidosis: A Growing Threat to Heart Health
A once-rare condition, cardiac amyloidosis is increasingly being diagnosed thanks to advancements in medical imaging and a heightened awareness among clinicians. This pathology is characterized by the buildup of abnormal proteins, known as amyloid fibrils, within the heart muscle, leading to stiffness, thickening of the heart walls, and ultimately, heart failure.
Cardiac amyloidosis can be a complex and challenging disease, but significant progress is being made in both diagnosis and treatment, offering new hope to patients.
Understanding the Disease
Cardiac amyloidosis occurs when misfolded proteins accumulate in the heart, disrupting its normal function. These amyloid deposits impede the heart’s ability to effectively fill with blood, gradually leading to a decline in cardiac performance. For years, the condition was considered exceptionally uncommon, but that is changing.
Two Primary Forms of Cardiac Amyloidosis
Not all forms of amyloidosis are the same, and understanding the specific type is crucial for effective treatment. The two most frequently observed forms affecting the heart are:
- Transthyretin Amyloidosis (ATTR): This form can be linked to the natural aging process – often referred to as “wild-type” – or result from an inherited genetic mutation.
- AL Amyloidosis (from light chains): This type is associated with an underlying blood disorder, specifically a plasma cell dyscrasia, and demands swift, comprehensive medical intervention.
Recognizing the Symptoms
The signs of cardiac amyloidosis can be subtle and often mimic other, more common conditions, making early diagnosis difficult. Common symptoms include:
- Breathlessness (dyspnea), particularly during physical exertion.
- Persistent tiredness and weakness.
- Swelling in the legs and ankles (edema).
Beyond these cardiac-specific symptoms, many patients also experience non-cardiac manifestations such as carpal tunnel syndrome (often affecting both hands), tingling sensations in the extremities, and digestive issues.
Diagnosis and Treatment at Auxologico
At Auxologico, patients suspected of having amyloidosis benefit from comprehensive diagnostic pathways. These include advanced imaging techniques like cardiac color Doppler echocardiography and cardiac magnetic resonance imaging (MRI), alongside assessments for heart failure and other related conditions.
New Therapeutic Horizons
The outlook for patients with amyloidosis is significantly brighter than it once was. Innovative therapies, including transthyretin stabilizers and gene silencers, are now available. These treatments have the potential to substantially slow disease progression and improve patients’ overall quality of life.
The development of these new drugs represents a major step forward in the fight against this challenging disease, offering renewed hope for those affected.
